Remission after rituximab for HHV8+ MCD: what next?
作者信息
Ramaswami Ramya, Uldrick Thomas S
机构信息
HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Oncology, Fred Hutchinson Cancer Center, Seattle, WA.
出版信息
Blood Adv. 2023 Sep 26;7(18):5661-5662. doi: 10.1182/bloodadvances.2023011043.
Abstract
摘要
相似文献
1
Remission after rituximab for HHV8+ MCD: what next?利妥昔单抗治疗HHV8阳性多中心Castleman病后的缓解：接下来该怎么做？
Blood Adv. 2023 Sep 26;7(18):5661-5662. doi: 10.1182/bloodadvances.2023011043.
2
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease.利妥昔单抗成功治疗一名HHV8阳性、HIV阴性的老年日本多中心Castleman病患者。
Int J Hematol. 2022 Jan;115(1):129-134. doi: 10.1007/s12185-021-03222-7. Epub 2021 Sep 30.
3
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.利妥昔单抗治疗 HHV8+多中心 Castleman 病后，HIV-患者比 HIV+患者进展更快。
Blood Adv. 2023 Sep 26;7(18):5663-5669. doi: 10.1182/bloodadvances.2023010316.
4
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.HHV8 阳性、HIV 阴性多中心 Castleman 病：利妥昔单抗治疗的早期和持续完全缓解，无卡波西肉瘤再激活。
Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
5
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.利妥昔单抗治疗 HIV 阳性患者后，HHV8 阳性多中心 Castleman 病复发。
Blood. 2017 Apr 13;129(15):2143-2147. doi: 10.1182/blood-2016-10-747477. Epub 2017 Jan 31.
6
Overview of Castleman disease.卡斯特曼病概述。
Blood. 2020 Apr 16;135(16):1353-1364. doi: 10.1182/blood.2019000931.
7
8
Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.白细胞介素6受体抗体托珠单抗治疗HIV相关多中心Castleman病患者的短期疗效：两例报告
J Hematol Oncol. 2014 Jan 17;7:10. doi: 10.1186/1756-8722-7-10.
9
Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.人类疱疹病毒 8 相关多中心 Castleman 病合并晚期 HIV 感染患者：一例报告。
Medicine (Baltimore). 2021 Dec 10;100(49):e28077. doi: 10.1097/MD.0000000000028077.
10
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease.利妥昔单抗治疗 HIV 相关多中心 Castleman 病患者的疗效改善。
Blood. 2011 Sep 29;118(13):3499-503. doi: 10.1182/blood-2011-02-333633. Epub 2011 Jul 21.
本文引用的文献
1
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.接受泊马度胺治疗后卡波氏肉瘤患者的免疫表型分析。
AIDS. 2023 Sep 1;37(11):1693-1703. doi: 10.1097/QAD.0000000000003627. Epub 2023 Jun 19.
2
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.利妥昔单抗治疗 HHV8+多中心 Castleman 病后，HIV-患者比 HIV+患者进展更快。
Blood Adv. 2023 Sep 26;7(18):5663-5669. doi: 10.1182/bloodadvances.2023010316.
3
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.卡波西肉瘤相关多中心型 Castleman 病伴或不伴其他 KSHV 疾病的特征和结局。
Blood Adv. 2021 Mar 23;5(6):1660-1670. doi: 10.1182/bloodadvances.2020004058.
4
A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma.经典型和 HIV 病毒血症及无病毒血症艾滋病性卡波西肉瘤的对比研究。
AIDS. 2021 Mar 1;35(3):399-405. doi: 10.1097/QAD.0000000000002744.
5
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.利妥昔单抗治疗 HIV 阳性患者后，HHV8 阳性多中心 Castleman 病复发。
Blood. 2017 Apr 13;129(15):2143-2147. doi: 10.1182/blood-2016-10-747477. Epub 2017 Jan 31.
6
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.HHV-8 多中心 Castleman 病中 iNKT 和记忆 B 细胞的改变。
Blood. 2017 Feb 16;129(7):855-865. doi: 10.1182/blood-2016-06-719716. Epub 2016 Nov 9.
7
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.人类和病毒白细胞介素-6 和其他细胞因子在卡波西肉瘤疱疹病毒相关的多中心 Castleman 病中的作用。
Blood. 2013 Dec 19;122(26):4189-98. doi: 10.1182/blood-2013-08-519959. Epub 2013 Oct 30.
8
Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.血浆 HHV8 DNA 可预测 HIV 相关多中心 Castleman 病患者的复发。
Blood. 2011 Jul 14;118(2):271-5. doi: 10.1182/blood-2011-02-335620. Epub 2011 Apr 21.
9
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.利妥昔单抗治疗HIV相关多中心Castleman病期间的细胞因子变化
Blood. 2009 May 7;113(19):4521-4. doi: 10.1182/blood-2008-12-197053. Epub 2009 Feb 17.
10
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.利妥昔单抗治疗依赖化疗的人类免疫缺陷病毒相关多中心Castleman病的前瞻性研究：ANRS 117 CastlemaB试验
J Clin Oncol. 2007 Aug 1;25(22):3350-6. doi: 10.1200/JCO.2007.10.6732.
Zotero 插件